C Champions Oncology Inc
C
Chiusa
SettoreSettore sanitario
4.71 -2.69
Panoramica
Variazione del prezzo dell'azione
24h
Minimo
4.66
Massimo
4.83
Entrata | 241K -426K |
|---|---|
Vendite | 1.4M 15M |
P/E Media del settore | 35.118 48.735 |
EPS | -0.03 |
Margine di Profitto | -2.797 |
Dipendenti | 214 |
EBITDA | 79K -95K |
Utili prossimi | 14 dic 2026 |
|---|
Capitalizzazione di Mercato | -3.6M 69M |
|---|---|
Apertura precedente | 7.4 |
Chiusura precedente | 4.71 |
Champions Oncology Inc Grafico
Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.
Notizie correlate
Confronto tra pari
Modifica del prezzo
Champions Oncology Inc Previsione
Notizie finanziarie
Spese di vendita e di amministrazione
Spese operative
Utile prima delle imposte
Vendite
Costo delle vendite
Utile lordo sulle vendite
Interessi passivi sul debito
EBITDA
Utile operativo
$
Chi Siamo Champions Oncology Inc
Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.